Review
Ascites and hepatorenal syndrome: pathogenesis and treatment strategies
Affiliations
- PMID: 9506180
Item in Clipboard
Review
Ascites and hepatorenal syndrome: pathogenesis and treatment strategies
Adv Intern Med.
1998.
No abstract available
Similar articles
-
Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. International Ascites Club.Hepatology. 1996 Jan;23(1):164-76. doi: 10.1002/hep.510230122. Hepatology. 1996. PMID: 8550036 Review. No abstract available.
-
[Physiopathology of refractory ascites and the hepatorenal syndrome].Nefrologia. 2002;22 Suppl 5:41-6. Nefrologia. 2002. PMID: 12107916 Review. Spanish. No abstract available.
-
[Treatment of ascites, hyponatremia and hepatorenal syndrome in liver cirrhosis].Ther Umsch. 2009 Nov;66(11):747-51. doi: 10.1024/0040-5930.66.11.747. Ther Umsch. 2009. PMID: 19885792 Review. German.
-
[Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].Gastroenterol Hepatol. 2004 Feb;27 Suppl 1:8-14. Gastroenterol Hepatol. 2004. PMID: 15195529 Review. Spanish. No abstract available.
-
Pathogenetic factors and clinical elements in ascites and hepatorenal syndrome during liver cirrhosis.Ann Ital Med Int. 1999 Oct-Dec;14(4):264-84. Ann Ital Med Int. 1999. PMID: 10638019 Review.
Cited by
-
Preserved renal function during long-term follow-up in children with chronic liver disease.Acta Paediatr. 2022 Jun;111(6):1267-1273. doi: 10.1111/apa.16306. Epub 2022 Mar 5. Acta Paediatr. 2022. PMID: 35188684 Free PMC article.
-
Arginine vasopressin (AVP) and treatment with arginine vasopressin receptor antagonists (vaptans) in congestive heart failure, liver cirrhosis and syndrome of inappropriate antidiuretic hormone secretion (SIADH).Eur J Clin Pharmacol. 2011 Apr;67(4):333-346. doi: 10.1007/s00228-011-1006-7. Epub 2011 Feb 17. Eur J Clin Pharmacol. 2011. PMID: 21327910 Review.